Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression.

Neuropsychiatric Disease and Treatment
A TadicN Dahmen

Abstract

This study investigated the possible association of the interleukin-1 beta (IL-1beta) C-511T promoter polymorphism and the interleukin-1 receptor antagonist (IL-1Ra) (86bp)(n) variable number of tandem repeats (VNTR) polymorphism with antidepressant response to paroxetine and mirtazapine treatment. The study group consisted of 101 patients suffering from DSM-IV major depression participating in a randomized double-blind controlled clinical trial. Patients homozygous for the IL-1beta-511T allele had a significantly faster and more pronounced response to paroxetine treatment than IL-1beta-511C allele carriers. No association was found for the IL-1beta C-511T polymorphism with mirtazapine treatment response. The IL-1Ra VNTR showed neither an association with paroxetine nor with mirtazapine treatment response. Our results provide further suggestive evidence that time course of response and antidepressant efficacy of paroxetine, but not of mirtazapine, is influenced in a clinically relevant manner by the IL-1beta C-511T gene variant. Our data do not support the hypothesis that the IL-1Ra (86bp)(n) VNTR affects antidepressant treatment response to paroxetine or mirtazapine. An independent replication of our finding is needed. If repl...Continue Reading

References

Nov 13, 1995·Biochemical and Biophysical Research Communications·S RamamoorthyV Ganapathy
May 7, 1998·Acta Psychiatrica Scandinavica·F Brambilla, M Maggioni
Aug 12, 1999·Advances in Experimental Medicine and Biology·A J DunnT Ando
Aug 12, 1999·Advances in Experimental Medicine and Biology·H Anisman, Z Merali
Nov 24, 1999·Neuropsychobiology·J LevineV Barak
Oct 13, 2000·The Journal of Clinical Psychiatry·O BenkertR Kohnen
Mar 10, 2001·Acta Psychiatrica Scandinavica·B M OwenA H Young
Mar 14, 2001·Journal of Affective Disorders·M RothermundtH Kirchner
Apr 3, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·R YirmiyaJ Weidenfeld
Jul 19, 2001·Journal of Biopharmaceutical Statistics·C H MallinckrodtS R David
Oct 29, 2002·Brain, Behavior, and Immunity·Nathalie CastanonRaz Yirmiya
Dec 6, 2002·The International Journal of Neuropsychopharmacology·Gunter Kenis, Michael Maes
Apr 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Younger W-Y YuShih-Jen Tsai
May 6, 2003·Journal of Biopharmaceutical Statistics·Craig H MallinckrodtGeert Molenbergh
Mar 31, 2004·Brain, Behavior, and Immunity·Hymie Anisman
Dec 31, 2004·The American Journal of Psychiatry·Alan J ThomasJohn T O'Brien
Feb 8, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Olga J G SchiepersMichael Maes
Jun 21, 2005·The International Journal of Neuropsychopharmacology·Ewa ObuchowiczZbigniew S Herman
Dec 1, 2005·Trends in Immunology·Charles L RaisonAndrew H Miller
Feb 3, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Chong-Bin ZhuWilliam A Hewlett
Aug 7, 2007·Experimental Physiology·Julio LicinioMa-Li Wong

❮ Previous
Next ❯

Citations

Jun 17, 2014·Expert Opinion on Drug Metabolism & Toxicology·Chiara FabbriAlessandro Serretti
Feb 15, 2014·Biomarkers in Medicine·Charlotte MartinTimothy R Powell
Sep 8, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Chiara FabbriAlessandro Serretti
Oct 27, 2016·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jacob BarnesCarmine M Pariante
Apr 28, 2018·Expert Review of Molecular Diagnostics·Cristina MoraAnnamaria Cattaneo
Jul 16, 2013·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Chiara FabbriAlessandro Serretti
Apr 12, 2016·Journal of Alzheimer's Disease : JAD·Qing YeZhijun Zhang
Aug 8, 2018·Frontiers in Psychiatry·Maria ShadrinaPetr A Slominsky
Oct 6, 2020·Brain and Neuroscience Advances·Nichola M Brydges, Jack Reddaway
Oct 18, 2020·Molecular and Cellular Neurosciences·Jack Reddaway, Nichola M Brydges
Jan 22, 2013·ACS Chemical Neuroscience·Nicole L Baganz, Randy D Blakely
Aug 10, 2021·Psychiatry Research. Neuroimaging·Metodi DraganovMaria J Portella

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
PCR
electrophoresis

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics
V L MisenerInternational Consortium for Childhood-Onset Mood
Neuropsychobiology
V L MisenerInternational Consortium for Childhood-Onset Mood Disorders
© 2022 Meta ULC. All rights reserved